Teaneck, NJ, September 1, 2024 – Regional Cancer Care Associates (RCCA), one of the nation’s largest networks of oncology specialists, today announced that Hematology Oncology Specialists of Cape Cod (HOSCC) and its three medical oncologists/hematologists will join RCCA effective September 1, 2024.
“All of us at RCCA are thrilled to welcome Hematology Oncology Specialists of Cape Cod to our ranks. We look forward to working with and supporting the practice and its physicians as they continue to provide outstanding, comprehensive care to the people of Cape Cod,” said Terrill Jordan, the president and chief executive officer of RCCA. Headquartered in Teaneck, NJ, the RCCA network includes more than 90+ cancer specialists providing comprehensive care in more than 24 community-based offices in New Jersey, Connecticut, Maryland, and the Washington, DC area.
Strategic Affiliation Enhances Cutting Edge Patient Care
Victor Aviles, MD, who founded Hematology Oncology Specialists of Cape Cod in 2006, said, “We chose to affiliate with Regional Cancer Care Associates because RCCA shares our practice’s commitment to providing patients with the latest in evidence-based therapies and highly personalized, compassionate care in a convenient setting close to their homes. RCCA offers a wealth of resources that will enable us to remain on the cutting edge as cancer care continues to evolve rapidly. Those resources include access to hundreds of clinical trials and RCCA’s sophisticated data analytics, which will power our ongoing efforts to individualize treatment decisions to optimal effect and to provide high-quality care in the most efficient manner possible.” Dr. Aviles added, “My HOSCC colleagues and I also welcome this affiliation with Regional Cancer Care Associates because RCCA – like us – is dedicated to preserving physician autonomy and leadership, which is essential to ensuring that all decisions are made with the best interests of the patient in mind.”
Comprehensive Care Close to Home: HOSCC's Expert Team and Services
With offices at 26 Edgerton Drive, Suite A, in North Falmouth, MA, Hematology Oncology Specialists of Cape Cod offers area residents treatment for solid tumors, hematologic malignancies, and non-cancerous blood conditions, such as anemia and clotting disorders. In addition to Dr. Aviles, the practice’s medical staff includes board-certified medical oncologists/hematologists Hannah Yamin, DO, and Jaffar Hilli, MD.
A Unified Vision for Enhanced Patient Outcomes: RCCA Welcomes New Specialists
Iuliana Shapira, MD, the Chief Medical Officer of RCCA, said, “I am delighted to welcome Drs. Aviles, Yamin, and Hilli to RCCA. I look forward to our future collaboration and to learning from one another as we harness the scientific evidence and our collective experience to further enhance outcomes and quality of life for our patients.”
Expanding Expertise: RCCA's Continued Growth with New Affiliations
Mr. Jordan, RCCA’s president and chief executive officer, noted that Hematology Oncology Specialists of Cape Cod is the second oncology practice to join Regional Cancer Care Associates in as many months, with New Jersey Cancer Care and its three offices and seven physicians having affiliated with RCCA in July 2024.
“We are honored that both practices and their physicians have chosen to become part of RCCA, and we are excited about what the future holds as we work together to provide patients with excellent care in welcoming, community-based centers near their homes,” he said.
About RCCA
Established in 2012, Regional Cancer Care Associates (RCCA) has more than 90+ cancer specialists providing community-based care in more than 24 offices in New Jersey, Connecticut, Maryland, and the Washington, DC area. RCCA oncologists and hematologists see approximately 26,000 new patients each year and provide care to more than 245,000 established patients, collaborating closely with those patients’ other physicians. RCCA specialists offer patients innovative therapies, including immunotherapies and targeted therapy, as well as access to approximately 300 clinical trials. In addition to serving patients who have solid tumors, blood-based cancers, and benign blood disorders, RCCA care centers also provide infusion services to people with a number of non-oncologic conditions—including multiple sclerosis, Crohn’s disease, asthma, iron-deficiency anemia, and rheumatoid arthritis—who take intravenously-administered medications.
About Hematology Oncology Specialists of Cape Cod
Founded in 2006 by Victor Aviles, MD, and his wife, Ann M. DeWeer-Aviles, MD, a pediatrician, HOSCC provides care for all types of cancers and hematologic disorders. The practice’s three medical oncologists/hematologists are on staff at Falmouth Hospital, where Dr. Aviles is Chief of Hematology and Oncology. Additionally, they routinely collaborate with their colleagues at Massachusetts General Hospital, where Dr. Aviles is a Consultant in Medicine, Dana-Farber Cancer Institute, and other centers.
Located at 26 Edgerton Drive, Suite A, in North Falmouth, MA, the practice has an onsite laboratory for patient convenience and to facilitate timely clinical assessment and decision-making. The practice is open from 9:00 a.m. to 5:00 p.m. Monday through Friday, except for major holidays. One of the practice’s physicians is always on call for medical emergencies on weekends, holidays, and after-hours.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
RCCA is pleased to announce the recognition of John Theurer Cancer Center as the #1 Cancer Program in New Jersey by U.S. News and World Report.
Regional Cancer Care Associates (RCCA), one of the nation’s largest cancer care networks, offers Marylanders access to some of the nation’s leading oncologists and hematologists.
Affiliation provides oncology practice with expanded resources as it pursues its commitment to providing patients with the latest therapies and best possible outcomes.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.
